Stage
No active trials
Next date
None yet
Trials
0 active
1 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- Main trialPhase 3
- “The study will evaluate the effect of NTRA-2112 on intestinal malabsorption in preterm infants.”In the company’s words, NCT02510560 on ClinicalTrials.gov
Other drugs for Premature Birth of Newborn
- Aerosolized CalfactantONY · Phase 3
- SIBP-A16Shanghai Institute Of Biological Products · Phase 1/2
- PNEUMOSTEMMedipost Co Ltd. · Phase 2
Coming up0
No dates coming up.
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials1
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Terminated | 25 Apr 2018 | Study to Assess the Efficacy and Safety of NTRA-2112 on Intestinal Malabsorption in Preterm Infants |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 20 Nov 2026 · EU trials register (CTIS) updated 20 Nov 2026 · openFDA updated 20 Nov 2026